---
title: "Zhitong A-share lock-up release overview | December 20"
description: "On December 20th, 10 listed companies will have their restricted shares unlocked, with a total market value of approximately 10.615 billion yuan. The unlocking situation includes JYC 66.1376 million s"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/222865824.md"
published_at: "2024-12-20T01:01:07.000Z"
---

# Zhitong A-share lock-up release overview | December 20

> On December 20th, 10 listed companies will have their restricted shares unlocked, with a total market value of approximately 10.615 billion yuan. The unlocking situation includes JYC 66.1376 million shares, SUNYES 3.4655 million shares, Boteng Co., Ltd. 90,800 shares, HIRON COLD CHAIN 64,200 shares, RAYNEN 199,500 shares, Gan & Lee 1.234 million shares, Yonghe Co., Ltd. 1.6303 million shares, Zhiyou Technology 19.8465 million shares, Anbang Guardian 1.85484 million shares, and Hemai Co., Ltd. 4.1422 million shares

According to the Zhitong Finance APP, on December 20th, a total of 10 listed companies will have their restricted shares unlocked, with a total market value of approximately 10.615 billion yuan.

The specific situation of the restricted share unlock today is as follows:

Stock Abbreviation

Stock Code

Restricted Share Type

Number of Unlocked Shares

JYC

000546

Issuance of A-shares for legal person allocation

6.61376 million

SUNYES

002388

Equity incentive restricted circulation

346,550

Boteng Co., Ltd.

300363

Equity incentive restricted circulation

90,800

HIRON COLD CHAIN

603187

Equity incentive restricted circulation

64,200

RAYNEN

603933

Equity incentive restricted circulation

199,500

Gan & Lee

603087

Equity incentive restricted circulation

1,234,000

Yonghe Co., Ltd.

605020

Equity incentive restricted circulation

1,630,300

Zhiyou Technology

301376

Extended restricted lock-up period circulation

19.8465 million

Anbang Guardian

603373

Pre-issuance share restricted circulation

18.5484 million

Hemai Co., Ltd.

688032

41.422 million

### Related Stocks

- [603933.CN - RAYNEN](https://longbridge.com/en/quote/603933.CN.md)
- [603187.CN - HIRON COLD CHAIN](https://longbridge.com/en/quote/603187.CN.md)
- [002388.CN - SUNYES](https://longbridge.com/en/quote/002388.CN.md)
- [000546.CN - JYC](https://longbridge.com/en/quote/000546.CN.md)
- [603087.CN - Gan & Lee](https://longbridge.com/en/quote/603087.CN.md)
- [301376.CN - Ziel Home Furnishing Technology](https://longbridge.com/en/quote/301376.CN.md)
- [000001.CN - SSE Index](https://longbridge.com/en/quote/000001.CN.md)
- [300363.CN - Porton](https://longbridge.com/en/quote/300363.CN.md)
- [688032.CN - Hoymiles](https://longbridge.com/en/quote/688032.CN.md)
- [603373.CN - Anbang Save-Guard](https://longbridge.com/en/quote/603373.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Trump's department of injustice: Impunity for friends, brutality for enemies | The article critiques the Trump administration's approach to justice, highlighting a culture of impunity for allies and  | [Link](https://longbridge.com/en/news/277491350.md) |
| Henlius Biotech Doses First Patient in Phase 2/3 Breast Cancer Drug Study; Shares Slip 3% | Henlius Biotech Doses First Patient in Phase 2/3 Breast Cancer Drug Study; Shares Slip 3% | [Link](https://longbridge.com/en/news/277421361.md) |
| Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals | Hong Kong-listed Chinese pharmaceutical companies are poised for profitability due to rising drug sales and lucrative li | [Link](https://longbridge.com/en/news/277340041.md) |
| Athletics-Navigation nightmare derails leaders at US half marathon championship | The U.S. half marathon championship was marred by a navigation error when a guide vehicle misled the top three women run | [Link](https://longbridge.com/en/news/277367812.md) |
| LESS NOISE, BETTER SIGNALS: HOW PHARMA CAN MEASURE IMPACT AS AI RESHAPES SEARCH | The article discusses the transformation of search in the pharmaceutical industry due to AI adoption, emphasizing the sh | [Link](https://longbridge.com/en/news/277470520.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.